FDA
-
-
-
-
-
-
-
Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American
-
-
-
-
-
-
-
AZTR receives NYSE delisting warning over equity requirement
-
-
-
-
-
-
-
Azitra, Inc (AZTR) Reports Safety Data from Phase 1b Trial in Netherton Syndrome
-
-
-
-
-
-
-
Azitra, Inc (AZTR) Announces $20M Share Purchase Agreement with Alumni Capital to Fund Clinical Pipeline
-
-
-
-
-
-
-
Azitra, Inc. to Present at The Microcap Conference
-
-
-
-
-
-
-
Azitra to Present at BIO-Europe 2024
-
-
-
-
-
-
-
Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

